Saran, Frank http://orcid.org/0000-0002-3448-5064
Welsh, Liam
James, Allan
McBain, Catherine
Gattamaneni, Rao
Jefferies, Sarah
Harris, Fiona
Pemberton, Karine
Schaible, Jennifer
Bender, Shaun
Cseh, Agnieszka
Brada, Michael
Clinical trials referenced in this document:
Documents that mention this clinical trial
Afatinib and radiotherapy, with or without temozolomide, in patients with newly diagnosed glioblastoma: results of a phase I trial
https://doi.org/10.1007/s11060-021-03877-6
Funding for this research was provided by:
Boehringer Ingelheim
Article History
Received: 3 August 2021
Accepted: 13 October 2021
First Online: 17 November 2021
Declarations
:
: SJ reports having a private medical practice for CNS and Thyroid tumors, having an investment in Genesis Cancer Care at Newmarket within a Limited Company – Saunders and Jefferies Consultancy, and undertaking medicolegal work (one-two cases per year). KP declares being a Global project Manager working for Boehringer Ingelheim. JS declares employment with Boehringer Ingelheim Pharma GmbH & Co KG. SB declares employment with Boehringer Ingelheim Pharmaceuticals, Inc. AC declares employment with Boehringer Ingelheim International GmbH. All remaining authors declare no potential conflict of interest. The authors did not receive payment related to the development of the manuscript.
: The study was approved by the Ethics Committee of the NHS Health Research Authority London (West London and Gene Therapy Advisory Committee). All patients provided written informed consent according to International Conference on Harmonization Good Clinical Practice and local legal regulations. Patients included in the current study provided written consent for the usage of their data for research purposes.